Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary
- Author
- STAESSEN, Jan A (Commentator (written text))
1 ; RICHART, Tom (Commentator (written text))
1 ; OGAWA, Kazuhiko2 ; KANAE, Kiyoshi2 ; KAWAI, Makoto2 ; SEKI, Shingo2 ; OKAZAKI, Fumiko2 ; TANIGUCHI, Masayuki2 ; YOSHIDA, Satoru2 ; TAJIMA, Naoko4 ; MOCHIZUKI, Seibu2 ; DAHLOF, Bjöm3 ; SHIMIZU, Mitsuyuki2 ; IKEWAKI, Katsunori2 ; YOSHIKAWA, Makoto2 ; TANIGUCHI, Ikuo2 ; OHTA, Makoto2 ; YAMADA, Taku2
[1] Studies Coordinating Centre, Division of Hypertension and Cardiovascular Rehabilitation, Department of Cardiovascular Diseases, Campus Gasthuisberg, University of Leuven, 3000 Leuven, Belgium
[2] Division of Cardiology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
[3] Institute of Medicine, Department of Emergency and Cardiovascular Medicine, sahlgrenska University Hospital/Ostra, Göteborg, Sweden
[4] Division of Diabetes, Metabolism, and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo, Japan
Jikei Heart Study group - Source
Lancet (British edition). 2007, Vol 369, Num 9571 ; 1407-1408,1431-1439 [11 p.] ; ref : 49 ref
- CODEN
- LANCAO
- ISSN
- 0140-6736
- Scientific domain
- General medicine general surgery
- Publisher
- Lancet, London
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antihypertenseur Appareil circulatoire pathologie Cardiopathie Epidémiologie Essai clinique Homme Hypertension artérielle Japonais Morbidité Mortalité Médecine Médicament Population Randomisation Valsartan Essai ouvert Essai thérapeutique Maladie chronique Sartan dérivé Valine dérivé Japon Aminoacide Angiotensine II Antagoniste angiotensine Biphényle dérivé Hormone peptide Octapeptide Récepteur angiotensine AT1 Système renin angiotensine Tétrazole dérivé Asie
- Keyword (en)
- Antihypertensive agent Cardiovascular disease Heart disease Epidemiology Clinical trial Human Hypertension Japanese Morbidity Mortality Medicine Drug Population Randomization Valsartan Chronic disease Japan Aminoacid Angiotensin II Angiotensin antagonist Biphenyl derivatives Peptide hormone Octapeptide AT1 angiotensin receptor Renin angiotensin system Tetrazole derivatives Asia
- Keyword (es)
- Antihipertensivo Aparato circulatorio patología Cardiopatía Epidemiología Ensayo clínico Hombre Hipertensión arterial Japonés Morbilidad Mortalidad Medicina Medicamento Población Aleatorización Valsartán Enfermedad crónica Japón Aminoácido Angiotensina II Antagonista angiotensina Bifenilo derivado Hormona péptido Octapéptido Receptor angiotensina AT1 Sistema renin angiotensina Tetrazol derivado Asia
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B05 Arterial hypertension. Arterial hypotension
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B30 Public health. Hygiene-occupational medicine / 002B30A Public health. Hygiene / 002B30A01 General aspects / 002B30A01A Epidemiology
- Discipline
- Cardiology. Circulatory system Generalities in medical sciences Public health. Hygiene-occupational medicine
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18682666
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:4:\"9571\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:27:\"1407-1408,1431-1439 [11 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"STAESSEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jan A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:12:\"RICHART, Tom\";i:1;s:15:\"OGAWA, Kazuhiko\";i:2;s:14:\"KANAE, Kiyoshi\";i:3;s:13:\"KAWAI, Makoto\";i:4;s:12:\"SEKI, Shingo\";i:5;s:15:\"OKAZAKI, Fumiko\";i:6;s:19:\"TANIGUCHI, Masayuki\";i:7;s:15:\"YOSHIDA, Satoru\";i:8;s:13:\"TAJIMA, Naoko\";i:9;s:16:\"MOCHIZUKI, Seibu\";i:10;s:13:\"DAHLOF, Bj\u00f6m\";i:11;s:18:\"SHIMIZU, Mitsuyuki\";i:12;s:18:\"IKEWAKI, Katsunori\";i:13;s:17:\"YOSHIKAWA, Makoto\";i:14;s:15:\"TANIGUCHI, Ikuo\";i:15;s:12:\"OHTA, Makoto\";i:16;s:12:\"YAMADA, Taku\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:6:\"Lancet\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:4:\"9571\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:27:\"1407-1408,1431-1439 [11 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"STAESSEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jan A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:12:\"RICHART, Tom\";i:1;s:15:\"OGAWA, Kazuhiko\";i:2;s:14:\"KANAE, Kiyoshi\";i:3;s:13:\"KAWAI, Makoto\";i:4;s:12:\"SEKI, Shingo\";i:5;s:15:\"OKAZAKI, Fumiko\";i:6;s:19:\"TANIGUCHI, Masayuki\";i:7;s:15:\"YOSHIDA, Satoru\";i:8;s:13:\"TAJIMA, Naoko\";i:9;s:16:\"MOCHIZUKI, Seibu\";i:10;s:13:\"DAHLOF, Bj\u00f6m\";i:11;s:18:\"SHIMIZU, Mitsuyuki\";i:12;s:18:\"IKEWAKI, Katsunori\";i:13;s:17:\"YOSHIKAWA, Makoto\";i:14;s:15:\"TANIGUCHI, Ikuo\";i:15;s:12:\"OHTA, Makoto\";i:16;s:12:\"YAMADA, Taku\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:6:\"Lancet\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:4:\"9571\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:27:\"1407-1408,1431-1439 [11 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"STAESSEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jan A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:12:\"RICHART, Tom\";i:1;s:15:\"OGAWA, Kazuhiko\";i:2;s:14:\"KANAE, Kiyoshi\";i:3;s:13:\"KAWAI, Makoto\";i:4;s:12:\"SEKI, Shingo\";i:5;s:15:\"OKAZAKI, Fumiko\";i:6;s:19:\"TANIGUCHI, Masayuki\";i:7;s:15:\"YOSHIDA, Satoru\";i:8;s:13:\"TAJIMA, Naoko\";i:9;s:16:\"MOCHIZUKI, Seibu\";i:10;s:13:\"DAHLOF, Bj\u00f6m\";i:11;s:18:\"SHIMIZU, Mitsuyuki\";i:12;s:18:\"IKEWAKI, Katsunori\";i:13;s:17:\"YOSHIKAWA, Makoto\";i:14;s:15:\"TANIGUCHI, Ikuo\";i:15;s:12:\"OHTA, Makoto\";i:16;s:12:\"YAMADA, Taku\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:6:\"Lancet\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:4:\"9571\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:27:\"1407-1408,1431-1439 [11 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"STAESSEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jan A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:12:\"RICHART, Tom\";i:1;s:15:\"OGAWA, Kazuhiko\";i:2;s:14:\"KANAE, Kiyoshi\";i:3;s:13:\"KAWAI, Makoto\";i:4;s:12:\"SEKI, Shingo\";i:5;s:15:\"OKAZAKI, Fumiko\";i:6;s:19:\"TANIGUCHI, Masayuki\";i:7;s:15:\"YOSHIDA, Satoru\";i:8;s:13:\"TAJIMA, Naoko\";i:9;s:16:\"MOCHIZUKI, Seibu\";i:10;s:13:\"DAHLOF, Bj\u00f6m\";i:11;s:18:\"SHIMIZU, Mitsuyuki\";i:12;s:18:\"IKEWAKI, Katsunori\";i:13;s:17:\"YOSHIKAWA, Makoto\";i:14;s:15:\"TANIGUCHI, Ikuo\";i:15;s:12:\"OHTA, Makoto\";i:16;s:12:\"YAMADA, Taku\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:6:\"Lancet\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:9:\"\u0000*\u0000jtitle\";s:24:\"Lancet (British edition)\";s:9:\"\u0000*\u0000stitle\";s:16:\"Lancet (Br. ed.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:3:\"369\";s:8:\"\u0000*\u0000issue\";s:4:\"9571\";s:8:\"\u0000*\u0000spage\";s:0:\"\";s:8:\"\u0000*\u0000epage\";s:0:\"\";s:8:\"\u0000*\u0000pages\";s:27:\"1407-1408,1431-1439 [11 p.]\";s:7:\"\u0000*\u0000issn\";s:9:\"0140-6736\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:8:\"STAESSEN\";s:10:\"\u0000*\u0000aufirst\";s:5:\"Jan A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:17:{i:0;s:12:\"RICHART, Tom\";i:1;s:15:\"OGAWA, Kazuhiko\";i:2;s:14:\"KANAE, Kiyoshi\";i:3;s:13:\"KAWAI, Makoto\";i:4;s:12:\"SEKI, Shingo\";i:5;s:15:\"OKAZAKI, Fumiko\";i:6;s:19:\"TANIGUCHI, Masayuki\";i:7;s:15:\"YOSHIDA, Satoru\";i:8;s:13:\"TAJIMA, Naoko\";i:9;s:16:\"MOCHIZUKI, Seibu\";i:10;s:13:\"DAHLOF, Bj\u00f6m\";i:11;s:18:\"SHIMIZU, Mitsuyuki\";i:12;s:18:\"IKEWAKI, Katsunori\";i:13;s:17:\"YOSHIKAWA, Makoto\";i:14;s:15:\"TANIGUCHI, Ikuo\";i:15;s:12:\"OHTA, Makoto\";i:16;s:12:\"YAMADA, Taku\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"LANCAO\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:188:\"Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study) : a randomised, open-label, blinded endpoint morbidity-mortality study. Commentary\";s:8:\"\u0000*\u0000place\";s:6:\"London\";s:6:\"\u0000*\u0000pub\";s:6:\"Lancet\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
